Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
07. November 2024 07:00 ET
|
Tilray Brands, Inc.
This trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from negative chemotherapy-induced side effects.
Moxie and Organic Remedies MO Begin Cannabis Production in Missouri After Signing Strategic Alliance Agreement
16. September 2022 09:00 ET
|
Moxie
ST. LOUIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Today, Moxie™(MXY Holdings, Inc "Moxie"), the first licensed cannabis company in California and a leading multi-state cannabis operator, product...